Eisai And Biogen's LEQEMBI Pen Cleared In Japan For Early Alzheimer's Disease, Backed By Clarity AD Study And Long-Term Extension Sub-Studies

뉴스 본문을 불러오고 있어요.

Eisai And Biogen's LEQEMBI Pen Cleared In Japan For Early Alzheimer's Disease, Backed By Clarity AD Study And Long-Term Extension Sub-Studies | 웨이프 WAPE

Eisai And Biogen's LEQEMBI Pen Cleared In Japan For Early Alzheimer's Disease, Backed By Clarity AD Study And Long-Term Extension Sub-Studies

기사 요약

관련 종목

댓글 —